The FDA’s decision on Novavax’s COVID-19 vaccine could come in weeks By: MarketWatch May 26, 2022 at 11:15 AM EDT The company's protein-based shot has been authorized or approved in several other countries, including the U.K. and Singapore. Read More >> Related Stocks: Amgen BioNTech SE - American Depositary Shares Johnson & Johnson Moderna, Inc. - Common Stock Novavax, Inc. - Common Stock Pfizer
